Curis, Inc. ("Curis") (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, yesterday presented data ...
If you buy something, we may earn an affiliate commission. She adds that the best winter running hats are pretty impressive multitaskers—they’ll help you stay warm while preventing you from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback